From evidence to policy: #ESGVH Chair Prof @oana-sandulescu.bsky.social invited to present our position paper on #HepA vaccination at the @vhpb.bsky.social meeting in Antwerp, contributing to European discussions on closing immunity gaps & advancing prevention.
lnkd.in/dnff7Bgg
@escmid.bsky.social

Honoured to be hosting the upcoming @eswinfluenza.bsky.social Science Policy Interface Roundtable in Romania.

A fantastic opportunity to foster relevant discussions with key stakeholders in order to improve control of vaccine-preventable diseases 👏

#Influenza #RSV #Vaccines

Just back from a PhD committee at @uio.no 🎓

Impressive RCT of ~20,000 participants showed: #HEV vaccine safe in adults but should be avoided before and during early pregnancy.

And the timing: just a day after the Nobel Prize in Medicine announcement!

lnkd.in/eiV97GCb

🗓️ 🕒 Save the date for #ESWI2027: The largest European-based influenza conference returns for its 11th edition in Valencia, 26-29 September 2027. Subscribe to our newsletter to be the first to receive updates: eswi.org/form/newslet...

🍄 #BalkanFungus in 🇷🇴 - landmark meeting for #MedicalMycology

I shared an update on #cryptococcus, from screening and early recognition to diagnosis & management. Early diagnosis can make all the difference 💙

Congratulations @efisg-escmid.bsky.social and the amazing Cluj team!

@escmid.bsky.social

Chronic liver disease can be destabilised by #influenza and other respiratory infections. Honored that our #ESGVH Chair, Prof. @oana-sandulescu.bsky.social joins the #ESWI Board to connect liver health, vaccination and respiratory prevention.
@escmid.bsky.social
@eswinfluenza.bsky.social

A new #EUCIC #IPC cohort in Ljubljana 💫
Fantastic evolution in a program we were piecing together several years ago.
#AMS take-home:
Tailor your ab choice. Your AMS plan.
To your country. Your setting. Your patient.
Evidence travels. Good stewardship adapts.
@escmid.bsky.social
@eucic.bsky.social

Truly honored to join #ESWI and to be part of such an exceptional group of board members&experts.

Looking forward to contributing my expertise and exchanging ideas to advance influenza science and public health.

Grateful for the opportunity. Excited for the work ahead.

@eswinfluenza.bsky.social

Honoured and proud that our Chair, Prof. @oana-sandulescu.bsky.social delivered a fantastic keynote at #ESCV2026 in Porto!

“Practical ART decision-making in HIV-HBV coinfection” - a timely reminder that HBV status matters in ART decisions.

#HIV #HBV
@escvirology.bsky.social
@escmid.bsky.social

Friday morning = keynote time at #ESCV2026 in Porto!

My keynote: Practical ART decision-making in HIV-HBV coinfection

4 patient trajectories
4 ART decisions
4 things to know

The message? HBV matters.

Thank you @escvirology.bsky.social 👏👏
@esgvh.bsky.social
@escmid.bsky.social

⏰ TIME TO REGISTER!

🌍 Major international experts in viral hepatitis - all in one place.

Join ESGVH for 3 days covering hepatitis A–E, emerging viruses & challenging cases.

📅 27–29 Nov 2026 | 💻 Online

👉 Register now lnkd.in/e53ChGBN

@escmid.bsky.social

Starting in 3 hours!

Join us:

HCV Elimination: A Multi-society Perspective on Progress, Gaps and Next Steps

📅 10 September 2026

⏰ 3 pm CEST

💻 Zoom

🔗 Participation is free.

Register here:
lnkd.in/e577hvey

@aasldnews.bsky.social
@idsainfo.bsky.social
@inhsu.bsky.social
@escmid.bsky.social

A thought to carry into autumn 🍂

At #ESC2026, I was invited to discuss the cardioprotective role of high-dose flu vaccination for the elderly.

A great example of ID&cardio shared responsibility for the same patient.

Flu prevention is also CV prevention 💉❤️
@escardio.bsky.social
@medscape.com